FDA Clearance Tracker · P890055-S030
MEDSTREAM PROGRAMMABLE INFUSION SYSTEM
Last checked: Nov 20, 2026Latest source record: Mar 15, 2011 (this decision)Source: openFDAMethods & limitations
Decided
Mar 15, 2011
Approved
Time to decision
56 days
Received Jan 18, 2011. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P890055-S030
- Device name
- MEDSTREAM PROGRAMMABLE INFUSION SYSTEM
- Applicant
- Intera Oncology
- Applicant location
- Newton, MA
- Received
- Jan 18, 2011
- Decided
- Mar 15, 2011
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Postapproval Study Protocol - OSB
- Original approval
- P890055
Device type
- Device class
- Class III
- Specialty
- Hospital Medicine & Nursing
FDA's approval statement
As written in FDA's record.
APPROVAL OF THE POST-APPROVAL PROTOCOL.
Source documents
Other decisions for Intera Oncology
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Intera Refill Kit510(k)
K213823 · Decided Mar 16, 2022 · 98 days after receipt
Device type: Non-Coring (Huber) Needle (PTI) · Hospital Medicine & Nursing
K211121 · Decided Oct 14, 2021 · 182 days after receipt
Device type: Non-Coring (Huber) Needle (PTI) · Hospital Medicine & Nursing
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.